Target Name: BLOC1S1
NCBI ID: G2647
Review Report on BLOC1S1 Target / Biomarker Content of Review Report on BLOC1S1 Target / Biomarker
BLOC1S1
Other Name(s): GCN5L1 | BLOC-1 subunit 1 | BLOC subunit 1 | BLOC1S1 variant 1 | biogenesis of lysosomal organelles complex 1 subunit 1 | BORCS1 | Biogenesis of lysosome-related organelles complex 1 subunit 1 | RT14 | GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1 | BL1S1_HUMAN | BLOS1 | Biogenesis of lysosomal organelles complex 1 subunit 1, transcript variant 1 | MICoA | MTA1-interacting coactivator | Protein RT14 | GCN5-like protein 1 | GCN5 general control of amino-acid synthesis 5-like 1

BLOC1S1: A Potential Drug Target and Biomarker

BLOC1S1 (GcN5L1) is a protein that is expressed in various tissues of the body, including the brain. It is a key regulator of cell-cell adhesion, and has been implicated in a number of neurological and psychiatric disorders. Despite its importance, little is known about BLOC1S1 and its potential as a drug target or biomarker.

In recent years, the study of protein-protein interactions (PPIs) has gained significant attention as a means of understanding the complex networks of proteins that are involved in various cellular processes. PPIs are the interactions between two or more proteins that occur in a cell, and can play a critical role in the regulation of cellular processes such as cell growth, differentiation, and inflammation.

One of the most promising avenues for the study of PPIs is the identification of protein-protein interaction (PPI) domains that are involved in the regulation of cellular processes. These domains are often characterized by a conserved sequence pattern that is present in multiple proteins, and can be used to predict the likely interactions between different proteins.

One of the most well-studied PPI domains is the coiled-coil (CC) domain. CC domains are characterized by a specific arrangement of amino acids that give the protein a CC-like structure. Many studies have shown that CC domains are involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling pathways.

BLOC1S1 is a protein that is characterized by a CC domain. The CC domain is present in multiple proteins, including GLI1, NG2, and PDGFR-尾. It is made up of 115 amino acids and is involved in the regulation of several cellular processes, including cell adhesion and migration.

One of the most interesting aspects of the CC domain is its ability to form a stable interaction with other proteins. This interaction is known as a \"dimerization\" interaction, and is characterized by the formation of a stable complex between the protein's amino acids. This interaction can be important for the regulation of cellular processes because it allows proteins to interact with each other and to work together in the regulation of various cellular processes.

BLOC1S1 is also known for its role in the regulation of cell-cell adhesion. Adhesion is the process by which cells stick together and form tissues. This process is critical for the development and maintenance of tissues and organs, and is also involved in the regulation of various diseases, including cancer.

One of the most interesting ways in which BLOC1S1 is involved in cell-cell adhesion is its role in the regulation of cadherin, a protein that is involved in cell-cell adhesion. Cadherins are a family of transmembrane proteins that are characterized by their ability to form a tight juncture between cells. They are involved in many different processes in the body, including the regulation of cell-cell adhesion, the development and maintenance of tissues and organs, and the regulation of various diseases.

BLOC1S1 is also involved in the regulation of tight junction formation, which is the process by which cells stick together and form tight junctions. This process is important for the regulation of cell-cell adhesion and is involved in the development and maintenance of tissues and organs.

In addition to its role in cell-cell adhesion, BLOC1S1 is also involved in the regulation of various signaling pathways. It is a target of several different signaling pathways, including the PI3K/Akt signaling pathway and the TGF-β signaling pathway. These signaling pathways are involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

The identification of a protein as a potential drug target or biomarker is based on its ability to interact with other proteins and to regulate various cellular processes. BLOC1S1 is a protein that is characterized by its ability

Protein Name: Biogenesis Of Lysosomal Organelles Complex 1 Subunit 1

Functions: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension (PubMed:17182842). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor (PubMed:25898167)

The "BLOC1S1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BLOC1S1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1 | BMP1 | BMP10 | BMP15 | BMP2 | BMP2K | BMP3 | BMP4 | BMP5 | BMP6 | BMP7 | BMP8A | BMP8B | BMPER | BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6